Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherArticle

Functional proliferating human hepatocytes: in vitro hepatocyte model for drug metabolism, excretion and toxicity

Shida Qiao, Sisi Feng, Zhitao Wu, Ting He, Chen Ma, Zhaoliang Peng, E Tian and Guoyu Pan
Drug Metabolism and Disposition February 1, 2021, DMD-AR-2020-000275; DOI: https://doi.org/10.1124/dmd.120.000275
Shida Qiao
1Shanghai Institute of Materia Medica, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sisi Feng
2Shanghai Hexaell Biotech Co., Ltd, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhitao Wu
3Shanghai Institute of Materia Medica; Nanjing University of Chinese Medicine, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ting He
4Nanjing Tech University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chen Ma
1Shanghai Institute of Materia Medica, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhaoliang Peng
1Shanghai Institute of Materia Medica, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Tian
2Shanghai Hexaell Biotech Co., Ltd, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gypan@simm.ac.cn
Guoyu Pan
1Shanghai Institute of Materia Medica, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gypan@simm.ac.cn
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

To develop a functional alternative hepatocyte model for primary human hepatocytes (PHH) with proliferative property, essential drug metabolic and transporter functions, proliferating human hepatocytes (ProliHH) expanded from PHH were fully characterized in vitro. Herein, ProliHH generated from multiple PHH donors could be expanded more than 200 folds within four passages, maintained their metabolic or transporter capacities partially, and further were able to regain of the mature hepatic property after three-dimensional (3D) culture. Particularly, the downregulated mRNA expression and function of three major CYP450 enzymes (CYP1A2, CYP2B6, and CYP3A4) in the proliferating process (ProliHH-P) could be recovered by 3D culture. The metabolic variabilities across different PHH donors could be inherited to their matured ProliHH (ProliHH-M). The intrinsic clearances (CLint) of seven major CYP450 enzymes in ProliHH-M were correlated well (r = 0.87) with that in PHH. Also, bile canaliculi structures could be observed in sandwich cultured ProliHH (SC-ProliHH), and the biliary excretion index (BEI) of four probe compounds (CLF, CDF, d8-TCA and rosuvastatin) in SC-ProliHH (>10%) were comparable to SC-PHH. More importantly, both ProliHH-P and ProliHH-M could be used to evaluate hepatotoxicity, and ProliHH-M were more suitable for transporter mediated drug hepatotoxicity evaluation. Therefore, these findings demonstrated that the 3D and sandwich culture system could be utilized to recover and maintain metabolic and transporter functions in ProliHH for clearance prediction and cholestasis risk assessment, respectively. ProliHH could be a promising substitute for PHH in drug metabolism, transport and hepatotoxicity screening.

Significance Statement We report the first demonstration that drug metabolic capacities and efflux transporter functions of ProliHH, as well as their potential in toxicity assessments. The metabolic variability in different primary human hepatocytes (PHH) donors could be inherited by their derived matured ProliHH. ProliHH could form canalicular networks in sandwich culture. These results make it feasible for ProliHH to support drug candidate screening in hepatic metabolism, disposition and toxicity.

  • biliary excretion
  • cell models
  • hepatocytes
  • hepatotoxicity
  • human CYP enzymes
  • Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics
Next
Back to top

In this issue

Drug Metabolism and Disposition: 51 (2)
Drug Metabolism and Disposition
Vol. 51, Issue 2
1 Feb 2023
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Functional proliferating human hepatocytes: in vitro hepatocyte model for drug metabolism, excretion and toxicity
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

Functional ProliHH derived from PHH

Shida Qiao, Sisi Feng, Zhitao Wu, Ting He, Chen Ma, Zhaoliang Peng, E Tian and Guoyu Pan
Drug Metabolism and Disposition February 1, 2021, DMD-AR-2020-000275; DOI: https://doi.org/10.1124/dmd.120.000275

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherArticle

Functional ProliHH derived from PHH

Shida Qiao, Sisi Feng, Zhitao Wu, Ting He, Chen Ma, Zhaoliang Peng, E Tian and Guoyu Pan
Drug Metabolism and Disposition February 1, 2021, DMD-AR-2020-000275; DOI: https://doi.org/10.1124/dmd.120.000275
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of payload-containing catabolites of ADCs
  • PK Interactions of Licorice with Cytochrome P450s
  • Biotransformation of Trastuzumab and Pertuzumab
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics